1
|
Emond C, DeVito MJ, Birnbaum LS. A physiologically based pharmacokinetic (PBPK) model describing the kinetics of a commercial mixture α-, β-, and γ-hexabromocyclododecane exposure in mice. Arch Toxicol 2025; 99:1043-1058. [PMID: 39847078 DOI: 10.1007/s00204-024-03939-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2024] [Accepted: 12/10/2024] [Indexed: 01/24/2025]
Abstract
Hexabromocyclododecane (HBCD) is a brominated flame retardant, that is added, but not chemically bonded, to consumer products. HBCD is sold as a commercial-grade HBCD mixture containing three major stereoisomers: alpha (α), beta (β), and gamma (γ), with relative amounts of 12% for α-HBCD, 6% for β-HBCD, and 82% for γ-HBCD. HBCDs are widely measured in the environment and in biological matrices. The toxicological effects of its exposure in humans are not clearly understood. A recent reassessment pointed out potential thyroid disruption as a primary effect. This current work aims to update a physiologically based pharmacokinetic (PBPK) model for γ-HBCD in C57BL/6 mice and incorporate equations and codes for α-HBCD and β-HBCD isomers and simulate them as a mixture. Physiological parameters were taken from the literature, calculated based on the log Kow or optimized with the dataset. The elimination of HBCDs in urine and feces was optimized to reflect the percent dose excreted, as published in the literature. Compared with data from the literature for α-HBCD, β-HBCD, and γ-HBCD in multiple tissues, the model simulations accurately described the pharmacokinetics of HBCDs in the mouse. The utility of the model was demonstrated by predicting blood concentrations from three studies in adult mice evaluating dopaminergic changes in the brain. Although this PBPK model for the mixture explicitly describes α-HBCD, β-HBCD, and γ-HBCD as individual exposures, but also as a mixture, more experimental data with commercial HBCD mixtures is still needed to improve the model.
Collapse
Affiliation(s)
- Claude Emond
- BioSimulation Consulting Inc., Crabtree, QC, Canada.
- School of Public Health, Department of Environmental and Occupational Health, University of Montreal, Montreal, QC, Canada.
| | - Michael J DeVito
- Center for Computational Toxicology and Exposure, Chemical Characterization and Exposure Division, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA
| | - Linda S Birnbaum
- Scientist Emeritus, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA
| |
Collapse
|
2
|
Pastorino P, Barceló D, Prearo M. Alps at risk: High-mountain lakes as reservoirs of persistent and emerging contaminants. JOURNAL OF CONTAMINANT HYDROLOGY 2024; 264:104361. [PMID: 38735086 DOI: 10.1016/j.jconhyd.2024.104361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/18/2024] [Revised: 04/30/2024] [Accepted: 05/03/2024] [Indexed: 05/14/2024]
Abstract
Despite their remote locations, high-mountain lakes located in the Alps are vulnerable to chemical pollution. This discussion explores the important aspects of these lakes as repositories of Persistent Organic Pollutants (POPs) and Contaminants of Emerging Concern (CECs), elucidating their sources and implications for both the environment and human health. In terms of the presence of POPs in high-altitude lakes of the Alps, 14 studies have been identified examining the occurrence of polychlorinated biphenyls, dichlorodiphenyltrichloroethane an its metabolites, polybrominated diphenyl ethers, and polycyclic aromatic hydrocarbons. The bulk of research on POPs in high-mountain lakes is concentrated in the Italian Alps (63%), followed by Switzerland (22%), Austria (12%), and France (3%), respectively. Sediment is predominantly investigated (65%), followed by fish (33%) and water (2%). Similarly, in relation to the presence of CECs in high-mountain lakes of the Alps, six studies have been identified investigating the occurrence of musks, perfluorinated compounds, and microplastics. Investigations into CECs predominantly occur in Switzerland (42%), France (33%), and Italy (25%), with fish samples (muscle and liver) being the primary focus (46%), followed by sediment (17%) and water (17%). Other compartments like zooplankton, frog/tadpoles, and snow remain less explored. The discussion also shed light on various pathways through which pollutants reach these remote landscapes, including atmospheric transport, glacial meltwater, and human activities. Protecting these pristine peaks demands concerted efforts encompassing ongoing research, vigilant monitoring, and dedicated conservation initiatives.
Collapse
Affiliation(s)
- Paolo Pastorino
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria, e Valle d'Aosta, via Bologna 148, 10154 Torino, Italy.
| | - Damià Barceló
- Institute of Environmental Assessment and Water Research (IDAEA-CSIC), 08034 Barcelona, Spain; Chemistry and Physics Department, University of Almeria, 04120 Almería, Spain
| | - Marino Prearo
- Istituto Zooprofilattico Sperimentale del Piemonte, Liguria, e Valle d'Aosta, via Bologna 148, 10154 Torino, Italy
| |
Collapse
|
3
|
Holuka C, Morel C, Roth S, Lamartinière Y, Mériaux SB, Paoli J, Guébels P, Duca RC, Godderis L, van Nieuwenhuyse A, Kremarik-Bouillaud P, Cariou R, Emond C, Schroeder H, Turner JD, Grova N. The epigenetic hallmark of early-life α-hexabromocyclododecane exposure: From cerebellar 6-mA levels to locomotor performance in adulthood. ENVIRONMENT INTERNATIONAL 2023; 178:108103. [PMID: 37494814 DOI: 10.1016/j.envint.2023.108103] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/05/2023] [Revised: 07/18/2023] [Accepted: 07/18/2023] [Indexed: 07/28/2023]
Abstract
There is a growing evidence that methylation at the N6 position of adenine (6-mA), whose modulation occurs primarily during development, would be a reliable epigenetic marker in eukaryotic organisms. The present study raises the question as to whether early-life exposure to α-hexabromocyclododecane (α-HBCDD), a brominated flame retardant, may trigger modifications in 6-mA epigenetic hallmarks in the brain during the development which, in turn could affect the offspring behaviour in adulthood. Pregnant Wistar rats were split into two groups: control and α-HBCDD (66 ng/kg/per os, G0-PND14). At PND1, α-HBCDD levels were assessed in brain and liver by LC-MS/MS. At PND14, DNA was isolated from the offspring's cerebellum. DNA methylation was measured by 6-mA-specific immunoprecipitation and Illumina® sequencing (MEDIP-Seq). Locomotor activity was finally evaluated at PND120. In our early-life exposure model, we confirmed that α-HBCDD can cross the placental barrier and be detected in pups at birth. An obvious post-exposure phenotype with locomotor deficits was observed when the rats reached adulthood. This was accompanied by sex-specific over-methylation of genes involved in the insulin signaling pathway, MAPK signaling pathway as well as serotonergic and GABAergic synapses, potentially altering the normal process of neurodevelopment with consequent motor impairments crystalized at adulthood.
Collapse
Affiliation(s)
- Cyrielle Holuka
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity-Luxembourg Institute of Health, 29 rue Henri Koch, L-4354 Esch-Sur-Alzette, Luxembourg; Faculty of Science, University of Luxembourg, L-4365 Belval, Luxembourg.
| | - Chloé Morel
- Calbinotox, Faculty of Science and Technology, University of Lorraine, Campus Aiguillettes, B.P. 70239, 54506 Vandoeuvre-lès-Nancy, France.
| | - Sarah Roth
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity-Luxembourg Institute of Health, 29 rue Henri Koch, L-4354 Esch-Sur-Alzette, Luxembourg.
| | - Yordenca Lamartinière
- Calbinotox, Faculty of Science and Technology, University of Lorraine, Campus Aiguillettes, B.P. 70239, 54506 Vandoeuvre-lès-Nancy, France.
| | - Sophie B Mériaux
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity-Luxembourg Institute of Health, 29 rue Henri Koch, L-4354 Esch-Sur-Alzette, Luxembourg.
| | - Justine Paoli
- Calbinotox, Faculty of Science and Technology, University of Lorraine, Campus Aiguillettes, B.P. 70239, 54506 Vandoeuvre-lès-Nancy, France.
| | - Pauline Guébels
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity-Luxembourg Institute of Health, 29 rue Henri Koch, L-4354 Esch-Sur-Alzette, Luxembourg.
| | - Radu C Duca
- Department of Health Protection, National Health Laboratory (LNS), Dudelange, Luxembourg; Centre for Environment and Health, University of Leuven (KU Leuven), Leuven, Belgium.
| | - Lode Godderis
- Centre for Environment and Health, University of Leuven (KU Leuven), Leuven, Belgium; IDEWE, External Service for Prevention and Protection at Work, Heverlee 3001, Belgium.
| | - An van Nieuwenhuyse
- Department of Health Protection, National Health Laboratory (LNS), Dudelange, Luxembourg; Centre for Environment and Health, University of Leuven (KU Leuven), Leuven, Belgium.
| | - Pascaline Kremarik-Bouillaud
- UMR Inserm 1256 nGERE, Nutrition-Génétique et exposition aux risques environnementaux, Institute of Medical Research (Pôle BMS), University of Lorraine, B.P. 184, 54511 Nancy, France.
| | | | - Claude Emond
- PKSH Inc., Crabtree, Quebec, Canada; School of Public Health, DSEST, University of Montreal, Montreal, Quebec, Canada.
| | - Henri Schroeder
- Calbinotox, Faculty of Science and Technology, University of Lorraine, Campus Aiguillettes, B.P. 70239, 54506 Vandoeuvre-lès-Nancy, France; UMR Inserm 1256 nGERE, Nutrition-Génétique et exposition aux risques environnementaux, Institute of Medical Research (Pôle BMS), University of Lorraine, B.P. 184, 54511 Nancy, France.
| | - Jonathan D Turner
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity-Luxembourg Institute of Health, 29 rue Henri Koch, L-4354 Esch-Sur-Alzette, Luxembourg.
| | - Nathalie Grova
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity-Luxembourg Institute of Health, 29 rue Henri Koch, L-4354 Esch-Sur-Alzette, Luxembourg; Calbinotox, Faculty of Science and Technology, University of Lorraine, Campus Aiguillettes, B.P. 70239, 54506 Vandoeuvre-lès-Nancy, France; UMR Inserm 1256 nGERE, Nutrition-Génétique et exposition aux risques environnementaux, Institute of Medical Research (Pôle BMS), University of Lorraine, B.P. 184, 54511 Nancy, France.
| |
Collapse
|
4
|
van der Schyff V, Kalina J, Govarts E, Gilles L, Schoeters G, Castaño A, Esteban-López M, Kohoutek J, Kukučka P, Covaci A, Koppen G, Andrýsková L, Piler P, Klánová J, Jensen TK, Rambaud L, Riou M, Lamoree M, Kolossa-Gehring M, Vogel N, Weber T, Göen T, Gabriel C, Sarigiannis DA, Sakhi AK, Haug LS, Murinova LP, Fabelova L, Tratnik JS, Mazej D, Melymuk L. Exposure to flame retardants in European children - Results from the HBM4EU aligned studies. Int J Hyg Environ Health 2023; 247:114070. [PMID: 36442457 PMCID: PMC9758617 DOI: 10.1016/j.ijheh.2022.114070] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2022] [Revised: 09/29/2022] [Accepted: 11/03/2022] [Indexed: 11/26/2022]
Abstract
Many legacy and emerging flame retardants (FRs) have adverse human and environmental health effects. This study reports legacy and emerging FRs in children from nine European countries from the HBM4EU aligned studies. Studies from Belgium, Czech Republic, Germany, Denmark, France, Greece, Slovenia, Slovakia, and Norway conducted between 2014 and 2021 provided data on FRs in blood and urine from 2136 children. All samples were collected and analyzed in alignment with the HBM4EU protocols. Ten halogenated FRs were quantified in blood, and four organophosphate flame retardants (OPFR) metabolites quantified in urine. Hexabromocyclododecane (HBCDD) and decabromodiphenyl ethane (DBDPE) were infrequently detected (<16% of samples). BDE-47 was quantified in blood from Greece, France, and Norway, with France (0.36 ng/g lipid) having the highest concentrations. BDE-153 and -209 were detected in <40% of samples. Dechlorane Plus (DP) was quantified in blood from four countries, with notably high median concentrations of 16 ng/g lipid in Slovenian children. OPFR metabolites had a higher detection frequency than other halogenated FRs. Diphenyl phosphate (DPHP) was quantified in 99% of samples across 8 countries at levels ∼5 times higher than other OPFR metabolites (highest median in Slovenia of 2.43 ng/g lipid). FR concentrations were associated with lifestyle factors such as cleaning frequency, employment status of the father of the household, and renovation status of the house, among others. The concentrations of BDE-47 in children from this study were similar to or lower than FRs found in adult matrices in previous studies, suggesting lower recent exposure and effectiveness of PBDE restrictions.
Collapse
Affiliation(s)
| | - Jiři Kalina
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, 2400, Belgium
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, 2400, Belgium
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, 2400, Belgium,Department of Biomedical Sciences, University of Antwerp, 2020, Antwerp, Belgium
| | - Argelia Castaño
- National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
| | - Marta Esteban-López
- National Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
| | - Jiři Kohoutek
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Petr Kukučka
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Adrian Covaci
- Toxicological Center, University of Antwerp, 2610 Wilrijk, Belgium
| | - Gudrun Koppen
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, 2400, Belgium
| | - Lenka Andrýsková
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Pavel Piler
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Jana Klánová
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic
| | - Tina Kold Jensen
- Department of Environmental Medicine, Institute of Public Health, University of Southern Denmark, Odense, 5000, Denmark
| | - Loic Rambaud
- Santé Publique France, French Public Health Agency (ANSP), Saint-Maurice, 94415, France
| | - Margaux Riou
- Santé Publique France, French Public Health Agency (ANSP), Saint-Maurice, 94415, France
| | - Marja Lamoree
- Vrije Universiteit, Amsterdam Institute for Life and Environment, Section Chemistry for Environment & Health, De Boelelaan 1108, 1081 HZ, Amsterdam, Netherlands
| | | | - Nina Vogel
- German Environment Agency (UBA), 06844 Dessau-Roßlau, Germany
| | - Till Weber
- German Environment Agency (UBA), 06844 Dessau-Roßlau, Germany
| | - Thomas Göen
- IPASUM - Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Henkestrasse 9-11, 91054, Erlangen, Germany
| | - Catherine Gabriel
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece
| | - Dimosthenis A. Sarigiannis
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece,HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece,Environmental Health Engineering, Institute of Advanced Study, Palazzo del Broletto, Piazza Della Vittoria 15, 27100, Pavia, Italy
| | - Amrit Kaur Sakhi
- Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | - Line Småstuen Haug
- Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | | | - Lucia Fabelova
- Faculty of Public Health, Slovak Medical University, Bratislava, 833 03, Slovakia
| | - Janja Snoj Tratnik
- Department of Environmental Sciences, Jožef Stefan Institute, Ljubljana, 1000, Slovenia
| | - Darja Mazej
- Department of Environmental Sciences, Jožef Stefan Institute, Ljubljana, 1000, Slovenia
| | - Lisa Melymuk
- RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic,Corresponding author.
| |
Collapse
|
5
|
Morel C, Emond C, Duca R, Debaugnies F, Borde P, Paoli J, Hardy E, Van Nieuwenhuyse A, Grova N, Schroeder H. P16-13 Assessing the role of pregnancy and the way of administration on the pharmacokinetic of valproic acid in rats in a context of gestational exposure to α-hexabromocyclododecane, a brominated flame retardant of high concern. Toxicol Lett 2022. [DOI: 10.1016/j.toxlet.2022.07.603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
6
|
Morel C, Christophe A, Maguin-Gaté K, Paoli J, Turner JD, Schroeder H, Grova N. Head-to-Head Study of Developmental Neurotoxicity and Resultant Phenotype in Rats: α-Hexabromocyclododecane versus Valproic Acid, a Recognized Model of Reference for Autism Spectrum Disorders. TOXICS 2022; 10:toxics10040180. [PMID: 35448441 PMCID: PMC9029525 DOI: 10.3390/toxics10040180] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/21/2022] [Revised: 04/01/2022] [Accepted: 04/04/2022] [Indexed: 02/04/2023]
Abstract
Evidence is now growing that exposure to environmental pollutants during the critical early-life period of brain development may contribute to the emergence of Autism Spectrum Disorders (ASD). This study seeks to compare the developmental neurotoxicity of the α-isomer of hexabromocyclododecane (α-HBCDD), a persistent brominated flame retardant, to the valproic acid (VPA) model of ASD in rodents. Pregnant Wistar rats were divided into three groups: control, α-HBCDD (100 ng/kg/day p.o., GD0-PND21) and VPA (600 mg/kg i.p., GD12). Male offspring were tested for their neuromotor development from PND2-21. At PND21, brain functionality was assessed by measuring cytochrome oxidase activity (CO). Modifications in neuroglia and synaptic plasticity were evaluated in the cortex. Similar subtle behavioural changes related to neuromotor maturation and noise reaction were observed in both treated groups. At PND21, a reduction in CO activity was measured in the VPA group only, in specific areas including auditory nuclei, visual cortex, cingulate and frontal cortices. At the same age, α-HBCDD pointed out significant overexpression of cortical markers of synaptic plasticity while both treated groups showed a significant under expression of astrocyte proteins (S100-β and GFAP). Early-life exposure to a low dose of α-HBCDD may trigger neurobehavioural alterations in line with ASD.
Collapse
Affiliation(s)
- Chloé Morel
- Calbinotox, EA7488, Université de Lorraine, 54506 Nancy, France; (C.M.); (A.C.); (K.M.-G.); (J.P.); (H.S.)
| | - Armelle Christophe
- Calbinotox, EA7488, Université de Lorraine, 54506 Nancy, France; (C.M.); (A.C.); (K.M.-G.); (J.P.); (H.S.)
| | - Katy Maguin-Gaté
- Calbinotox, EA7488, Université de Lorraine, 54506 Nancy, France; (C.M.); (A.C.); (K.M.-G.); (J.P.); (H.S.)
| | - Justine Paoli
- Calbinotox, EA7488, Université de Lorraine, 54506 Nancy, France; (C.M.); (A.C.); (K.M.-G.); (J.P.); (H.S.)
| | - Jonathan David Turner
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, 29 rue Henri Koch, L-4354 Esch-Sur-Alzette, Luxembourg;
| | - Henri Schroeder
- Calbinotox, EA7488, Université de Lorraine, 54506 Nancy, France; (C.M.); (A.C.); (K.M.-G.); (J.P.); (H.S.)
- Inserm U1256, NGERE, Université de Lorraine, 54000 Nancy, France
| | - Nathalie Grova
- Calbinotox, EA7488, Université de Lorraine, 54506 Nancy, France; (C.M.); (A.C.); (K.M.-G.); (J.P.); (H.S.)
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, 29 rue Henri Koch, L-4354 Esch-Sur-Alzette, Luxembourg;
- Inserm U1256, NGERE, Université de Lorraine, 54000 Nancy, France
- Correspondence:
| |
Collapse
|